GlassScriptPhysician profile
Amy M Waterman
NPI 1104335496
$605.07
in general payments reported to CMS, 2019-2025
14 companies · $81.27 in 2025
The $81.27 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.30 · 2022: $141 · 2023: $140 · 2024: $210 · 2025: $81.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $431.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $122.39 | 2023-2025 | Veozah, Myrbetriq |
| Amgen INC. | $77.70 | 2022-2025 | Evenity, Prolia |
| Mylan Specialty L.P. | $73.57 | 2022-2024 | Yupelri, Yupelri |
| Lilly USA, LLC | $65.55 | 2022-2024 | Jardiance, Mounjaro |
| Pfizer INC. | $58.28 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.69 | 2022-2023 | |
| Novo Nordisk INC | $40.86 | 2022-2025 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $18.79 | 2024 | Cologuard Collection Kit |
| Calliditas Therapeutics US INC. | $17.92 | 2025 | Tarpeyo |
| Mimedx Group, INC. | $17.38 | 2024 | |
| Genentech USA, INC. | $16.85 | 2021 | |
| Viatris Specialty LLC | $16.82 | 2025 | Yupelri |
| Medtronic, INC. | $12.93 | 2023 | Minimed 770g |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Waterman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.